Cita APA

Li, Y., Wang, Y., Niu, K., Chen, X., Xia, L., Lu, D., . . . Sun, J. (2016). Clinical benefit from EGFR-TKI plus ginsenoside Rg3 in patients with advanced non-small cell lung cancer harboring EGFR active mutation. Oncotarget.

Citación estilo Chicago

Li, Yan, et al. "Clinical Benefit From EGFR-TKI Plus Ginsenoside Rg3 in Patients With Advanced Non-small Cell Lung Cancer Harboring EGFR Active Mutation." Oncotarget 2016.

Cita MLA

Li, Yan, et al. "Clinical Benefit From EGFR-TKI Plus Ginsenoside Rg3 in Patients With Advanced Non-small Cell Lung Cancer Harboring EGFR Active Mutation." Oncotarget 2016.